首页 > 最新文献

Frontiers in Endocrinology最新文献

英文 中文
Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH). 社论:非酒精性脂肪性肝炎(NASH)的机理认识和治疗潜力。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1503460
Umashanker Navik, Amit Khurana, Jasvinder Singh Bhatti
{"title":"Editorial: Mechanistic insight and therapeutic potential for the management of non-alcoholic steatohepatitis (NASH).","authors":"Umashanker Navik, Amit Khurana, Jasvinder Singh Bhatti","doi":"10.3389/fendo.2024.1503460","DOIUrl":"https://doi.org/10.3389/fendo.2024.1503460","url":null,"abstract":"","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1503460"},"PeriodicalIF":3.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gut microbiota and metabolic profiles in adults with unclassified diabetes: a cross-sectional study. 未分类糖尿病成人的肠道微生物群和代谢特征:一项横断面研究。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1440984
Juan Zhang, Lei Wu, Zhongyun Zhang, Danjie Li, Rulai Han, Lei Ye, Yifei Zhang, Jie Hong, Weiqiong Gu

Aims: Our study, employing a multi-omics approach, aimed to delineate the distinct gut microbiota and metabolic characteristics in individuals under 30 with unclassified diabetes, thus shedding light on the underlying pathophysiological mechanisms.

Methods: This age- and sex-matched case-control study involved 18 patients with unclassified diabetes, 18 patients with classic type 1 diabetes, 13 patients with type 2 diabetes, and 18 healthy individuals. Metagenomics facilitated the profiling of the gut microbiota, while untargeted liquid chromatography-mass spectrometry was used to quantify the serum lipids and metabolites.

Results: Our findings revealed a unique gut microbiota composition in unclassified diabetes patients, marked by a depletion of Butyrivibrio proteoclasticus and Clostridium and an increase in Ruminococcus torques and Lachnospiraceae bacterium 8_1_57FAA. Comparative analysis identified the combined marker panel of five bacterial species, seven serum biomarkers, and three clinical parameters could differentiate patients with UDM from HCs with an AUC of 0.94 (95% CI 0.85-1). Notably, the gut microbiota structure of patients with unclassified diabetes resembled that of type 2 diabetes patients, especially regarding disrupted lipid and branched-chain amino acid metabolism.

Conclusions: Despite sharing certain metabolic features with type 2 diabetes, unclassified diabetes presents unique features. The distinct microbiota and metabolites in unclassified diabetes patients suggest a significant role in modulating glucose, lipid, and amino acid metabolism, potentially influencing disease progression. Further longitudinal studies are essential to explore therapeutic strategies targeting the gut microbiota and metabolites to modify the disease trajectory.

目的:我们的研究采用了多组学方法,旨在描述 30 岁以下未分类糖尿病患者的肠道微生物群和代谢特征,从而揭示其潜在的病理生理机制:这项年龄和性别匹配的病例对照研究涉及 18 名未分型糖尿病患者、18 名典型 1 型糖尿病患者、13 名 2 型糖尿病患者和 18 名健康人。元基因组学有助于分析肠道微生物群,而非靶向液相色谱-质谱法则用于量化血清脂质和代谢物:结果:我们的研究结果表明,未分类糖尿病患者的肠道微生物群组成独特,其特点是蛋白螯合梭状芽孢杆菌(Butyrivibrio proteoclasticus)和梭状芽孢杆菌(Clostridium)减少,瘤胃反刍球菌(Ruminococcus torques)和Lachnospiraceae细菌8_1_57FAA增加。比较分析发现,由五种细菌、七种血清生物标记物和三种临床参数组成的联合标记物面板可以将 UDM 患者与 HC 患者区分开来,其 AUC 为 0.94(95% CI 0.85-1)。值得注意的是,未分类糖尿病患者的肠道微生物群结构与2型糖尿病患者相似,尤其是在脂质和支链氨基酸代谢紊乱方面:结论:尽管未分类糖尿病与2型糖尿病具有某些共同的代谢特征,但未分类糖尿病具有独特的特征。未分类糖尿病患者体内独特的微生物群和代谢物表明,它们在调节葡萄糖、脂质和氨基酸代谢方面起着重要作用,可能会影响疾病的进展。进一步的纵向研究对于探索针对肠道微生物群和代谢物的治疗策略以改变疾病的发展轨迹至关重要。
{"title":"Gut microbiota and metabolic profiles in adults with unclassified diabetes: a cross-sectional study.","authors":"Juan Zhang, Lei Wu, Zhongyun Zhang, Danjie Li, Rulai Han, Lei Ye, Yifei Zhang, Jie Hong, Weiqiong Gu","doi":"10.3389/fendo.2024.1440984","DOIUrl":"10.3389/fendo.2024.1440984","url":null,"abstract":"<p><strong>Aims: </strong>Our study, employing a multi-omics approach, aimed to delineate the distinct gut microbiota and metabolic characteristics in individuals under 30 with unclassified diabetes, thus shedding light on the underlying pathophysiological mechanisms.</p><p><strong>Methods: </strong>This age- and sex-matched case-control study involved 18 patients with unclassified diabetes, 18 patients with classic type 1 diabetes, 13 patients with type 2 diabetes, and 18 healthy individuals. Metagenomics facilitated the profiling of the gut microbiota, while untargeted liquid chromatography-mass spectrometry was used to quantify the serum lipids and metabolites.</p><p><strong>Results: </strong>Our findings revealed a unique gut microbiota composition in unclassified diabetes patients, marked by a depletion of <i>Butyrivibrio proteoclasticus</i> and <i>Clostridium</i> and an increase in <i>Ruminococcus torques</i> and <i>Lachnospiraceae bacterium 8_1_57FAA</i>. Comparative analysis identified the combined marker panel of five bacterial species, seven serum biomarkers, and three clinical parameters could differentiate patients with UDM from HCs with an AUC of 0.94 (95% CI 0.85-1). Notably, the gut microbiota structure of patients with unclassified diabetes resembled that of type 2 diabetes patients, especially regarding disrupted lipid and branched-chain amino acid metabolism.</p><p><strong>Conclusions: </strong>Despite sharing certain metabolic features with type 2 diabetes, unclassified diabetes presents unique features. The distinct microbiota and metabolites in unclassified diabetes patients suggest a significant role in modulating glucose, lipid, and amino acid metabolism, potentially influencing disease progression. Further longitudinal studies are essential to explore therapeutic strategies targeting the gut microbiota and metabolites to modify the disease trajectory.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1440984"},"PeriodicalIF":3.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586653/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress in gasless endoscopic thyroidectomy. 无气内镜甲状腺切除术的进展。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1466837
Xianbin Cheng, Xiangfu Ding, Sijia Wang, Siyu Li, Hong Zhang

Gasless endoscopic thyroidectomy obviates the necessity for carbon dioxide insufflation to establish a surgical workspace, thus mitigating the potential complications associated with this practice. This technique presents several benefits, such as the maintenance of neck functionality, minimal scarring, and enhanced visibility of the surgical field, which contribute to its extensive adoption in clinical settings. The objective of this study is to synthesize the current methodologies of gasless endoscopic thyroidectomy and to evaluate the advantages and disadvantages inherent to each technique. It aims to offer theoretical insights to assist surgeons in determining the most suitable approach for gasless endoscopic thyroidectomy in their clinical practice.

无气内镜甲状腺切除术无需通过二氧化碳充气来建立手术工作区,从而减少了与这种做法相关的潜在并发症。这种技术具有多种优点,如保持颈部功能、瘢痕最小、手术视野更清晰等,因此在临床上被广泛采用。本研究的目的是总结目前无气内镜甲状腺切除术的方法,并评估每种技术固有的优缺点。研究旨在提供理论见解,帮助外科医生在临床实践中确定最适合的无气内镜甲状腺切除术方法。
{"title":"Progress in gasless endoscopic thyroidectomy.","authors":"Xianbin Cheng, Xiangfu Ding, Sijia Wang, Siyu Li, Hong Zhang","doi":"10.3389/fendo.2024.1466837","DOIUrl":"10.3389/fendo.2024.1466837","url":null,"abstract":"<p><p>Gasless endoscopic thyroidectomy obviates the necessity for carbon dioxide insufflation to establish a surgical workspace, thus mitigating the potential complications associated with this practice. This technique presents several benefits, such as the maintenance of neck functionality, minimal scarring, and enhanced visibility of the surgical field, which contribute to its extensive adoption in clinical settings. The objective of this study is to synthesize the current methodologies of gasless endoscopic thyroidectomy and to evaluate the advantages and disadvantages inherent to each technique. It aims to offer theoretical insights to assist surgeons in determining the most suitable approach for gasless endoscopic thyroidectomy in their clinical practice.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1466837"},"PeriodicalIF":3.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined high-intensity interval and resistance training improves cardiorespiratory fitness more than high-intensity interval training in young women with overweight/obesity: a randomized controlled trial. 高强度间歇训练和阻力训练相结合比高强度间歇训练更能改善超重/肥胖年轻女性的心肺功能:随机对照试验。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1450944
Yifei Wang, Xin Yang, Jiamei Deng, Zhenshan Wang, Dongxue Yang, Yanbai Han, Hongli Wang

Objective: This study aimed to compare the effects of high-intensity interval training (HIIT) combined with resistance training (RT) versus HIIT alone on body composition, cardiorespiratory fitness and glycolipid metabolism in young women with overweight/obesity.

Methods: This randomized controlled trial divided 40 subjects into an experimental group (HIIT+RT) and a control group (HIIT). Both groups underwent training three times per week for eight weeks. Body composition, cardiorespiratory fitness and glycolipid levels were assessed before and after the intervention.

Results: The results revealed that compared to baseline, both the experimental and control groups showed significant improvements in body weight, body mass index (BMI), Body fat, waist circumference (WC), waist-hip ratio (WHR), peak oxygen uptake (VO2peak), vital capacity (VC), oxygen pulse (VO2/HR), minute ventilation, resting heart rate, blood oxygen saturation, blood pressure, fasting blood glucose, triglycerides and high-density lipoprotein cholesterol (p<0.05). Additionally, a significant increase in muscle mass and a significant reduction in 2-hour postprandial glucose were observed in the experimental group (p<0.05). Muscle mass (mean difference: 2.75%), VO2peak (mean difference: 1.61 mL/min/kg), VC (mean difference: 334mL), and VO2/HR (mean difference: 0.51mL/beat) showed greater improvement in the HIIT+RT group compared to the HIIT group (p<0.05).

Conclusion: In conclusion, an 8-week regimen of either combined HIIT and RT or HIIT significantly improves body composition, cardiorespiratory fitness and glycolipid metabolism in women with overweight/obesity. However, the combined training appears to offer more benefits than HIIT alone. Further research is needed to evaluate the long-term effects and feasibility of combined training.

Trial registration: https://www.chictr.org.cn/, identifier ChiCTR2300075961.

研究目的本研究旨在比较高强度间歇训练(HIIT)结合阻力训练(RT)与单纯 HIIT 对超重/肥胖年轻女性的身体成分、心肺功能和糖脂代谢的影响:这项随机对照试验将 40 名受试者分为实验组(HIIT+RT)和对照组(HIIT)。两组均接受每周三次、为期八周的训练。干预前后对身体成分、心肺功能和糖脂水平进行了评估:结果显示,与基线相比,实验组和对照组在体重、体重指数(BMI)、体脂、腰围(WC)、腰臀比(WHR)、峰值摄氧量(VO2peak)、生命容量(VC)、氧脉搏(VO2/HR)、分钟通气量、静息心率、血氧饱和度、血压、空腹血糖、甘油三酯和高密度脂蛋白胆固醇(pp2peak(平均差异:1.61毫升/分钟/千克)、VC(平均差异:334毫升)和VO2/HR(平均差异:0.51毫升/次)显示,与HIIT组相比,HIIT+RT组有更大的改善(p结论:总之,为期 8 周的 HIIT 和 RT 或 HIIT 联合训练可显著改善超重/肥胖女性的身体成分、心肺功能和糖脂代谢。不过,联合训练似乎比单独的 HIIT 更有益处。需要进一步研究以评估联合训练的长期效果和可行性。试验注册:https://www.chictr.org.cn/,标识符为ChiCTR2300075961。
{"title":"Combined high-intensity interval and resistance training improves cardiorespiratory fitness more than high-intensity interval training in young women with overweight/obesity: a randomized controlled trial.","authors":"Yifei Wang, Xin Yang, Jiamei Deng, Zhenshan Wang, Dongxue Yang, Yanbai Han, Hongli Wang","doi":"10.3389/fendo.2024.1450944","DOIUrl":"10.3389/fendo.2024.1450944","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to compare the effects of high-intensity interval training (HIIT) combined with resistance training (RT) versus HIIT alone on body composition, cardiorespiratory fitness and glycolipid metabolism in young women with overweight/obesity.</p><p><strong>Methods: </strong>This randomized controlled trial divided 40 subjects into an experimental group (HIIT+RT) and a control group (HIIT). Both groups underwent training three times per week for eight weeks. Body composition, cardiorespiratory fitness and glycolipid levels were assessed before and after the intervention.</p><p><strong>Results: </strong>The results revealed that compared to baseline, both the experimental and control groups showed significant improvements in body weight, body mass index (BMI), Body fat, waist circumference (WC), waist-hip ratio (WHR), peak oxygen uptake (VO<sub>2</sub>peak), vital capacity (VC), oxygen pulse (VO<sub>2</sub>/HR), minute ventilation, resting heart rate, blood oxygen saturation, blood pressure, fasting blood glucose, triglycerides and high-density lipoprotein cholesterol (<i>p</i><0.05). Additionally, a significant increase in muscle mass and a significant reduction in 2-hour postprandial glucose were observed in the experimental group (<i>p</i><0.05). Muscle mass (mean difference: 2.75%), VO<sub>2</sub>peak (mean difference: 1.61 mL/min/kg), VC (mean difference: 334mL), and VO<sub>2</sub>/HR (mean difference: 0.51mL/beat) showed greater improvement in the HIIT+RT group compared to the HIIT group (<i>p</i><0.05).</p><p><strong>Conclusion: </strong>In conclusion, an 8-week regimen of either combined HIIT and RT or HIIT significantly improves body composition, cardiorespiratory fitness and glycolipid metabolism in women with overweight/obesity. However, the combined training appears to offer more benefits than HIIT alone. Further research is needed to evaluate the long-term effects and feasibility of combined training.</p><p><strong>Trial registration: </strong>https://www.chictr.org.cn/, identifier ChiCTR2300075961.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1450944"},"PeriodicalIF":3.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reduced expression of FOXE1 in differentiated thyroid cancer, the contribution of CPG methylation, and their clinical relevance. 分化型甲状腺癌中 FOXE1 的表达减少、CPG 甲基化的贡献及其临床意义。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1454349
Erika Urbano De Lima, Filipe Ferreira Dos Santos, Igor Campos Da Silva, Cláudio Rogério Alves De Lima, Vitoria Sousa Frutuoso, Gustavo Felisola Caso, Paloma Ramos De Oliveira, Ana Karina Bezerra, Janete Maria Cerutti, Rodrigo Esaki Tamura, Helton Estrela Ramos, Ileana Gabriela Sanchez de Rubio

Introduction: Forkhead box E1 (FOXE1) is a transcription factor with a crucial role in thyroid morphogenesis and differentiation. Promoter hypermethylation downregulates FOXE1 expression in different tumor types; nevertheless, its expression and relationship with methylation status in differentiated thyroid cancer (DTC) remain unclear.

Methods: A total of 33 pairs of matched samples of PTC tumors and non-tumors were included. Tumor cell cultures were treated with either 5-Aza-2'-deoxycytidine demethylating agent or dimethyl sulfoxide (DMSO). A real-time polymerase chain reaction (RT-PCR) and Western blotting were performed to assess FOXE1 expression. The methylation status was quantified using bisulfite sequencing. A luciferase gene assay was used to determine CpG-island functionality. Gene expression and promoter methylation of FOXE1 and FOXE1-regulated genes were also analyzed with data from The Cancer Genome Atlas (TCGA) thyroid samples.

Results: After demethylating treatment, increased FOXE1 mRNA was observed concomitantly with reduced promoter methylation of CpGisland2. A negative correlation between mRNA downregulation and an increased methylation level of CpGisland2 was observed in tumors. Diminished protein expression was also detected in some DTC cell lines and in some tumor samples, suggesting the involvement of post-transcriptional regulatory mechanisms. CPGisland2 was proved to be an enhancer. TCGA data analysis showed low FOXE1 mRNA expression in tumors with a negative correlation with methylation status and a positive correlation with the expression of most of its target genes. Reduced FOXE1 expression, accompanied by a high methylation level, was associated with PTC aggressiveness (tall cell variant, advanced extra thyroid extension, T4 American Joint Committee on Cancer (AJCC) classification), age at diagnosis (over 45 years old), and presence of a BRAFV600E mutation.

Conclusion: FOXE1 mRNA was downregulated in DTC compared with non-tumors, followed by high CpGisland methylation. A coupling of low mRNA expression and high methylation status was related to characteristics of aggressiveness in DTC tumors.

简介叉头盒E1(FOXE1)是一种转录因子,在甲状腺形态发生和分化过程中起着至关重要的作用。在不同类型的肿瘤中,启动子高甲基化会下调FOXE1的表达;然而,在分化型甲状腺癌(DTC)中,FOXE1的表达及其与甲基化状态的关系仍不清楚:方法:共纳入 33 对匹配的 PTC 肿瘤和非肿瘤样本。用 5-Aza-2'-deoxycytidine 去甲基化剂或二甲基亚砜(DMSO)处理肿瘤细胞培养物。采用实时聚合酶链反应(RT-PCR)和免疫印迹法评估 FOXE1 的表达。利用亚硫酸氢盐测序对甲基化状态进行量化。荧光素酶基因检测用于确定 CpG 岛的功能。还利用癌症基因组图谱(TCGA)甲状腺样本的数据分析了FOXE1和FOXE1调控基因的基因表达和启动子甲基化情况:结果:经过去甲基化处理后,在观察到FOXE1 mRNA增加的同时,CpGisland2启动子甲基化程度降低。在肿瘤中观察到 mRNA 下调与 CpGisland2 甲基化水平升高呈负相关。在一些 DTC 细胞系和一些肿瘤样本中也发现了蛋白表达的降低,这表明转录后调控机制的参与。CPGisland2 被证明是一个增强子。TCGA数据分析显示,肿瘤中FOXE1 mRNA表达量较低,与甲基化状态呈负相关,与大多数靶基因的表达呈正相关。FOXE1表达的降低以及高甲基化水平与PTC的侵袭性(高细胞变异、晚期甲状腺外扩展、T4美国癌症联合委员会(AJCC)分类)、诊断时的年龄(45岁以上)以及BRAFV600E突变的存在有关:结论:与非肿瘤相比,FOXE1 mRNA在DTC中下调,其次是高CpGisland甲基化。低 mRNA 表达和高甲基化状态与 DTC 肿瘤的侵袭性特征有关。
{"title":"Reduced expression of <i>FOXE1</i> in differentiated thyroid cancer, the contribution of CPG methylation, and their clinical relevance.","authors":"Erika Urbano De Lima, Filipe Ferreira Dos Santos, Igor Campos Da Silva, Cláudio Rogério Alves De Lima, Vitoria Sousa Frutuoso, Gustavo Felisola Caso, Paloma Ramos De Oliveira, Ana Karina Bezerra, Janete Maria Cerutti, Rodrigo Esaki Tamura, Helton Estrela Ramos, Ileana Gabriela Sanchez de Rubio","doi":"10.3389/fendo.2024.1454349","DOIUrl":"10.3389/fendo.2024.1454349","url":null,"abstract":"<p><strong>Introduction: </strong>Forkhead box E1 (<i>FOXE1</i>) is a transcription factor with a crucial role in thyroid morphogenesis and differentiation. Promoter hypermethylation downregulates <i>FOXE1</i> expression in different tumor types; nevertheless, its expression and relationship with methylation status in differentiated thyroid cancer (DTC) remain unclear.</p><p><strong>Methods: </strong>A total of 33 pairs of matched samples of PTC tumors and non-tumors were included. Tumor cell cultures were treated with either 5-Aza-2'-deoxycytidine demethylating agent or dimethyl sulfoxide (DMSO). A real-time polymerase chain reaction (RT-PCR) and Western blotting were performed to assess FOXE1 expression. The methylation status was quantified using bisulfite sequencing. A luciferase gene assay was used to determine CpG-island functionality. Gene expression and promoter methylation of FOXE1 and FOXE1-regulated genes were also analyzed with data from The Cancer Genome Atlas (TCGA) thyroid samples.</p><p><strong>Results: </strong>After demethylating treatment, increased <i>FOXE1</i> mRNA was observed concomitantly with reduced promoter methylation of CpGisland2. A negative correlation between mRNA downregulation and an increased methylation level of CpGisland2 was observed in tumors. Diminished protein expression was also detected in some DTC cell lines and in some tumor samples, suggesting the involvement of post-transcriptional regulatory mechanisms. CPGisland2 was proved to be an enhancer. TCGA data analysis showed low <i>FOXE1</i> mRNA expression in tumors with a negative correlation with methylation status and a positive correlation with the expression of most of its target genes. Reduced <i>FOXE1</i> expression, accompanied by a high methylation level, was associated with PTC aggressiveness (tall cell variant, advanced extra thyroid extension, T4 American Joint Committee on Cancer (AJCC) classification), age at diagnosis (over 45 years old), and presence of a <i>BRAFV600E</i> mutation.</p><p><strong>Conclusion: </strong><i>FOXE1</i> mRNA was downregulated in DTC compared with non-tumors, followed by high CpGisland methylation. A coupling of low mRNA expression and high methylation status was related to characteristics of aggressiveness in DTC tumors.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1454349"},"PeriodicalIF":3.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tissue adaptation to metabolic stress: insights from SUMOylation. 组织对代谢压力的适应:SUMOylation 的启示。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1434338
Hao Xie, Xin Liu, Shuo Li, Ming Wang, Ying Li, Ting Chen, Linwei Li, Faxi Wang, Xuan Xiao

Post-translational modification (PTM) plays a crucial role in adaptation of mammals to environmental changes, enabling them to survive in stressful situations. One such PTM is SUMO modification, which is evolutionarily conserved. It involves the covalent and reversible attachment of a small ubiquitin-like modifier (SUMO) to lysine (Lys) residues in the target protein. SUMOylation regulates various functions, including cell proliferation, differentiation, apoptosis, senescence, and maintenance of specific cellular activities. It achieves this by influencing protein-protein interactions, subcellular localization, protein stability, and DNA binding activity. Mounting evidence suggests that SUMOylation is implicated in the pathogenesis of metabolic disorders such as obesity, insulin resistance, and fatty liver. This review aims to provide an overview of the role of SUMOylation in regulating tissue adaptation to metabolic stress. Recent advancements in spectroscopic techniques have shed light on potential targets of SUMOylation and the underlying regulatory mechanisms have been elucidated, laying the theoretical foundation for the development of targeted SUMOylation interventions for metabolic syndrome while minimizing side effects.

翻译后修饰(PTM)在哺乳动物适应环境变化、使其在压力环境下生存方面发挥着至关重要的作用。SUMO 修饰就是这样一种 PTM,它在进化过程中得到了保留。它涉及一种小型泛素样修饰物(SUMO)与目标蛋白质中的赖氨酸(Lys)残基的共价和可逆连接。SUMOylation 可调节多种功能,包括细胞增殖、分化、凋亡、衰老和维持特定的细胞活动。它通过影响蛋白质与蛋白质之间的相互作用、亚细胞定位、蛋白质稳定性和 DNA 结合活性来实现这一目的。越来越多的证据表明,SUMOylation 与肥胖、胰岛素抵抗和脂肪肝等代谢性疾病的发病机制有关。本综述旨在概述 SUMOylation 在调节组织适应代谢压力方面的作用。光谱学技术的最新进展揭示了 SUMOylation 的潜在靶点,并阐明了潜在的调控机制,为开发针对代谢综合征的 SUMOylation 干预方法奠定了理论基础,同时最大限度地减少了副作用。
{"title":"Tissue adaptation to metabolic stress: insights from SUMOylation.","authors":"Hao Xie, Xin Liu, Shuo Li, Ming Wang, Ying Li, Ting Chen, Linwei Li, Faxi Wang, Xuan Xiao","doi":"10.3389/fendo.2024.1434338","DOIUrl":"10.3389/fendo.2024.1434338","url":null,"abstract":"<p><p>Post-translational modification (PTM) plays a crucial role in adaptation of mammals to environmental changes, enabling them to survive in stressful situations. One such PTM is SUMO modification, which is evolutionarily conserved. It involves the covalent and reversible attachment of a small ubiquitin-like modifier (SUMO) to lysine (Lys) residues in the target protein. SUMOylation regulates various functions, including cell proliferation, differentiation, apoptosis, senescence, and maintenance of specific cellular activities. It achieves this by influencing protein-protein interactions, subcellular localization, protein stability, and DNA binding activity. Mounting evidence suggests that SUMOylation is implicated in the pathogenesis of metabolic disorders such as obesity, insulin resistance, and fatty liver. This review aims to provide an overview of the role of SUMOylation in regulating tissue adaptation to metabolic stress. Recent advancements in spectroscopic techniques have shed light on potential targets of SUMOylation and the underlying regulatory mechanisms have been elucidated, laying the theoretical foundation for the development of targeted SUMOylation interventions for metabolic syndrome while minimizing side effects.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1434338"},"PeriodicalIF":3.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing type 2 diabetes mellitus prediction by integrating metabolomics and tree-based boosting approaches. 通过整合代谢组学和基于树的提升方法加强 2 型糖尿病的预测。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-11 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1444282
Ahmet Kadir Arslan, Fatma Hilal Yagin, Abdulmohsen Algarni, Erol Karaaslan, Fahaid Al-Hashem, Luca Paolo Ardigò

Background: Type 2 diabetes mellitus (T2DM) is a global health problem characterized by insulin resistance and hyperglycemia. Early detection and accurate prediction of T2DM is crucial for effective management and prevention. This study explores the integration of machine learning (ML) and explainable artificial intelligence (XAI) approaches based on metabolomics panel data to identify biomarkers and develop predictive models for T2DM.

Methods: Metabolomics data from T2DM (n = 31) and healthy controls (n = 34) were analyzed for biomarker discovery (mostly amino acids, fatty acids, and purines) and T2DM prediction. Feature selection was performed using the least absolute shrinkage and selection operator (LASSO) regression to enhance the model's accuracy and interpretability. Advanced three tree-based ML algorithms (KTBoost: Kernel-Tree Boosting; XGBoost: eXtreme Gradient Boosting; NGBoost: Natural Gradient Boosting) were employed to predict T2DM using these biomarkers. The SHapley Additive exPlanations (SHAP) method was used to explain the effects of metabolomics biomarkers on the prediction of the model.

Results: The study identified multiple metabolites associated with T2DM, where LASSO feature selection highlighted important biomarkers. KTBoost [Accuracy: 0.938; CI: (0.880-0.997), Sensitivity: 0.971; CI: (0.847-0.999), Area under the Curve (AUC): 0.965; CI: (0.937-0.994)] demonstrated its effectiveness in using complex metabolomics data for T2DM prediction and achieved better performance than other models. According to KTBoost's SHAP, high levels of phenylactate (pla) and taurine metabolites, as well as low concentrations of cysteine, laspartate, and lcysteate, are strongly associated with the presence of T2DM.

Conclusion: The integration of metabolomics profiling and XAI offers a promising approach to predicting T2DM. The use of tree-based algorithms, in particular KTBoost, provides a robust framework for analyzing complex datasets and improves the prediction accuracy of T2DM onset. Future research should focus on validating these biomarkers and models in larger, more diverse populations to solidify their clinical utility.

背景:2 型糖尿病(T2DM)是以胰岛素抵抗和高血糖为特征的全球性健康问题。早期检测和准确预测 T2DM 对于有效管理和预防至关重要。本研究探讨了基于代谢组学面板数据的机器学习(ML)和可解释人工智能(XAI)方法的整合,以确定生物标志物并开发 T2DM 的预测模型:对T2DM(31人)和健康对照组(34人)的代谢组学数据进行分析,以发现生物标志物(主要是氨基酸、脂肪酸和嘌呤)并预测T2DM。采用最小绝对收缩和选择算子(LASSO)回归法进行特征选择,以提高模型的准确性和可解释性。先进的三种基于树的 ML 算法(KTBoost:KTBoost: Kernel-Tree Boosting;XGBoost: eXtreme Gradient Boosting;NGBoost:采用这些生物标志物预测 T2DM。采用SHAPLE Additive exPlanations(SHAP)方法解释代谢组学生物标志物对模型预测的影响:研究发现了与 T2DM 相关的多种代谢物,其中 LASSO 特征选择突出了重要的生物标志物。KTBoost[准确度:0.938;CI:(0.880-0.997),灵敏度:0.971;CI:(0.847-0.999),曲线下面积(AUC):0.965;CI:(0.880-0.997),灵敏度:0.971;CI:(0.847-0.999):0.965; CI: (0.937-0.994)]证明了其在利用复杂代谢组学数据预测 T2DM 方面的有效性,并取得了比其他模型更好的性能。根据 KTBoost 的 SHAP,高水平的苯丙氨酸(pla)和牛磺酸代谢物以及低浓度的半胱氨酸、天门冬氨酸和半胱氨酸与 T2DM 的存在密切相关:代谢组学分析与 XAI 的整合为预测 T2DM 提供了一种前景广阔的方法。使用基于树的算法,特别是 KTBoost,为分析复杂数据集提供了一个稳健的框架,并提高了对 T2DM 发病的预测准确性。未来的研究应侧重于在更大规模、更多样化的人群中验证这些生物标志物和模型,以巩固它们的临床实用性。
{"title":"Enhancing type 2 diabetes mellitus prediction by integrating metabolomics and tree-based boosting approaches.","authors":"Ahmet Kadir Arslan, Fatma Hilal Yagin, Abdulmohsen Algarni, Erol Karaaslan, Fahaid Al-Hashem, Luca Paolo Ardigò","doi":"10.3389/fendo.2024.1444282","DOIUrl":"10.3389/fendo.2024.1444282","url":null,"abstract":"<p><strong>Background: </strong>Type 2 diabetes mellitus (T2DM) is a global health problem characterized by insulin resistance and hyperglycemia. Early detection and accurate prediction of T2DM is crucial for effective management and prevention. This study explores the integration of machine learning (ML) and explainable artificial intelligence (XAI) approaches based on metabolomics panel data to identify biomarkers and develop predictive models for T2DM.</p><p><strong>Methods: </strong>Metabolomics data from T2DM (n = 31) and healthy controls (n = 34) were analyzed for biomarker discovery (mostly amino acids, fatty acids, and purines) and T2DM prediction. Feature selection was performed using the least absolute shrinkage and selection operator (LASSO) regression to enhance the model's accuracy and interpretability. Advanced three tree-based ML algorithms (KTBoost: Kernel-Tree Boosting; XGBoost: eXtreme Gradient Boosting; NGBoost: Natural Gradient Boosting) were employed to predict T2DM using these biomarkers. The SHapley Additive exPlanations (SHAP) method was used to explain the effects of metabolomics biomarkers on the prediction of the model.</p><p><strong>Results: </strong>The study identified multiple metabolites associated with T2DM, where LASSO feature selection highlighted important biomarkers. KTBoost [Accuracy: 0.938; CI: (0.880-0.997), Sensitivity: 0.971; CI: (0.847-0.999), Area under the Curve (AUC): 0.965; CI: (0.937-0.994)] demonstrated its effectiveness in using complex metabolomics data for T2DM prediction and achieved better performance than other models. According to KTBoost's SHAP, high levels of phenylactate (pla) and taurine metabolites, as well as low concentrations of cysteine, laspartate, and lcysteate, are strongly associated with the presence of T2DM.</p><p><strong>Conclusion: </strong>The integration of metabolomics profiling and XAI offers a promising approach to predicting T2DM. The use of tree-based algorithms, in particular KTBoost, provides a robust framework for analyzing complex datasets and improves the prediction accuracy of T2DM onset. Future research should focus on validating these biomarkers and models in larger, more diverse populations to solidify their clinical utility.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1444282"},"PeriodicalIF":3.9,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142716016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between mental health and male fertility: depression, rather than anxiety, is linked to decreased semen quality. 心理健康与男性生育能力之间的关系:抑郁而非焦虑与精液质量下降有关。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-08 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1478848
Yi Zhang, Bei Chen, Yaqin Wang, Cong Liu, Jiayi Sun, Zhimo Zhang, Liangzi Guan, Ke Xiao, Zhonghai Zhu, Jin Luo

Background: Infertility is increasingly recognized as a global health issue affecting couples of reproductive age, with male factors contributing to approximately 50% of infertility cases. However, the association between depression and anxiety-two of the most prevalent mental health conditions-and impaired male fertility remains a subject of ongoing debate.

Methods: In this cross-sectional study, male participants seeking fertility counseling at an IVF clinic were recruited. Symptoms of depression and anxiety were assessed using the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7), respectively. Generalized linear regression models (GLMs) were employed to investigate the relationships between mental health status and semen parameters.

Results: Status of depression was negatively associated with semen quality parameters, whereas no statistically significant association was recognized between anxiety and semen quality except that sperm concentration was decreased by 25.60 (95% CI, 1.226 to 49.965, P=0.040) ×106/ml in moderate to severe anxiety group referring to normal group. Furthermore, when stratified by sleep duration, moderate to severe depression group showed a great decrease in progressive motility (PR), total motility, concentration and total sperm count (TSC) as referred to normal group in participants with sleep duration less than 7 hours.

Conclusion: The present study revealed that depression rather than anxiety was a negative factor that affected semen quality, especially in individuals with shorter sleep duration.

背景:不孕不育症日益被视为影响育龄夫妇的全球性健康问题,约50%的不孕不育症是由男性因素造成的。然而,抑郁和焦虑这两种最普遍的心理健康问题与男性生育能力受损之间的关系仍是一个争论不休的话题:在这项横断面研究中,招募了在一家试管婴儿诊所寻求生育咨询的男性参与者。抑郁和焦虑症状分别通过患者健康问卷-9(PHQ-9)和广泛性焦虑症-7(GAD-7)进行评估。采用广义线性回归模型(GLM)研究心理健康状况与精液参数之间的关系:结果:抑郁状态与精液质量参数呈负相关,而焦虑状态与精液质量之间没有统计学意义上的显著关联,但中重度焦虑组的精子浓度比正常组降低了 25.60(95% CI,1.226 至 49.965,P=0.040)×106/ml。此外,根据睡眠时间进行分层后,中度至重度抑郁组与正常组相比,睡眠时间少于 7 小时的参与者的进行性活力(PR)、总活力、浓度和总精子数(TSC)均有大幅下降:本研究表明,抑郁而非焦虑是影响精液质量的负面因素,尤其是在睡眠时间较短的人群中。
{"title":"Association between mental health and male fertility: depression, rather than anxiety, is linked to decreased semen quality.","authors":"Yi Zhang, Bei Chen, Yaqin Wang, Cong Liu, Jiayi Sun, Zhimo Zhang, Liangzi Guan, Ke Xiao, Zhonghai Zhu, Jin Luo","doi":"10.3389/fendo.2024.1478848","DOIUrl":"10.3389/fendo.2024.1478848","url":null,"abstract":"<p><strong>Background: </strong>Infertility is increasingly recognized as a global health issue affecting couples of reproductive age, with male factors contributing to approximately 50% of infertility cases. However, the association between depression and anxiety-two of the most prevalent mental health conditions-and impaired male fertility remains a subject of ongoing debate.</p><p><strong>Methods: </strong>In this cross-sectional study, male participants seeking fertility counseling at an IVF clinic were recruited. Symptoms of depression and anxiety were assessed using the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7), respectively. Generalized linear regression models (GLMs) were employed to investigate the relationships between mental health status and semen parameters.</p><p><strong>Results: </strong>Status of depression was negatively associated with semen quality parameters, whereas no statistically significant association was recognized between anxiety and semen quality except that sperm concentration was decreased by 25.60 (95% CI, 1.226 to 49.965, <i>P</i>=0.040) ×10<sup>6</sup>/ml in moderate to severe anxiety group referring to normal group. Furthermore, when stratified by sleep duration, moderate to severe depression group showed a great decrease in progressive motility (PR), total motility, concentration and total sperm count (TSC) as referred to normal group in participants with sleep duration less than 7 hours.</p><p><strong>Conclusion: </strong>The present study revealed that depression rather than anxiety was a negative factor that affected semen quality, especially in individuals with shorter sleep duration.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1478848"},"PeriodicalIF":3.9,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetically predicted serum ferritin mediates the association between inflammatory cytokines and non-alcoholic fatty liver disease. 基因预测的血清铁蛋白介导了炎症细胞因子与非酒精性脂肪肝之间的关联。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-08 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1437999
XiaoQian Liu, JianHong Jin, BaoFa Wang, LinPu Ge

Objective: Investigating the causal relationship between inflammatory cytokines and Non-alcoholic fatty liver disease(NAFLD) and identifying and quantifying the role of serum ferritin as a potential mediator.

Methods: Genetic summary statistics were derived from open genome-wide association study (GWAS) databases. We conducted a two-sample Mendelian randomization (MR) analysis to investigate the relationship between inflammatory cytokines (8,293 individuals) and NAFLD (8,434 cases, 770,180 controls). Furthermore, we used two-step MR to quantitate the proportion of the effect of serum ferritin-mediated inflammatory cytokines on NAFLD. In this study, we primarily utilized inverse-variance-weighted Mendelian randomization (MR-IVW) and reverse MR analysis methods, while other methods were also performed for sensitivity analysis, false discovery rate (FDR) <0.0012 as statistical significance in MR analyses.

Results: Our results indicated that high levels of Eotaxin, regulated upon activation normal T cell expressed and presumably secreted(RANTES), Interleukin-2(IL-2), macrophage migration inhibitory factor(MIF), tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) and Stem cell factor(SCF) were associated with increased risks of NAFLD, while high Cutaneous T cell-attracting chemokine(CTACK) and Interleukin-16(IL-16) levels that reduced the risk of NAFLD.The proportion of genetically predicted NAFLD mediated by ferritin was 2.1%(95% CI = 1.39%-5.61%).

Conclusion: In conclusion, our study identified a causal relationship between inflammatory cytokines and NAFLD, with a small proportion of the effect mediated by ferritin, but a majority of the effect of inflammatory cytokines on NAFLD remains unclear. Further research is needed on additional risk factors as potential mediators.

目的调查炎性细胞因子与非酒精性脂肪肝(NAFLD)之间的因果关系,并确定和量化血清铁蛋白作为潜在介质的作用:遗传摘要统计来自开放的全基因组关联研究(GWAS)数据库。我们进行了双样本孟德尔随机化(MR)分析,研究炎性细胞因子(8,293 人)与非酒精性脂肪肝(8,434 例病例,770,180 例对照)之间的关系。此外,我们还使用两步 MR 定量了血清铁蛋白介导的炎性细胞因子对非酒精性脂肪肝的影响比例。在这项研究中,我们主要采用了反方差加权孟德尔随机分析法(MR-IVW)和反向 MR 分析法,同时还采用了其他方法进行敏感性分析和误发现率(FDR)分析:我们的研究结果表明,高水平的Eotaxin、正常T细胞表达和分泌的活化调节因子(RANTES)、白细胞介素-2(IL-2)、巨噬细胞迁移抑制因子(MIF)、肿瘤坏死因子相关凋亡诱导配体(TRAIL)和干细胞因子(SCF)与非酒精性脂肪肝的风险增加有关,而皮肤T细胞吸引趋化因子(CTACK)和白细胞介素-16(IL-16)水平高则会降低非酒精性脂肪肝的风险。由铁蛋白介导的非酒精性脂肪肝基因预测比例为 2.1%(95% CI = 1.39%-5.61%):总之,我们的研究确定了炎性细胞因子与非酒精性脂肪肝之间的因果关系,其中一小部分影响由铁蛋白介导,但炎性细胞因子对非酒精性脂肪肝的大部分影响仍不清楚。需要进一步研究作为潜在介导因素的其他风险因素。
{"title":"Genetically predicted serum ferritin mediates the association between inflammatory cytokines and non-alcoholic fatty liver disease.","authors":"XiaoQian Liu, JianHong Jin, BaoFa Wang, LinPu Ge","doi":"10.3389/fendo.2024.1437999","DOIUrl":"10.3389/fendo.2024.1437999","url":null,"abstract":"<p><strong>Objective: </strong>Investigating the causal relationship between inflammatory cytokines and Non-alcoholic fatty liver disease(NAFLD) and identifying and quantifying the role of serum ferritin as a potential mediator.</p><p><strong>Methods: </strong>Genetic summary statistics were derived from open genome-wide association study (GWAS) databases. We conducted a two-sample Mendelian randomization (MR) analysis to investigate the relationship between inflammatory cytokines (8,293 individuals) and NAFLD (8,434 cases, 770,180 controls). Furthermore, we used two-step MR to quantitate the proportion of the effect of serum ferritin-mediated inflammatory cytokines on NAFLD. In this study, we primarily utilized inverse-variance-weighted Mendelian randomization (MR-IVW) and reverse MR analysis methods, while other methods were also performed for sensitivity analysis, false discovery rate (FDR) <0.0012 as statistical significance in MR analyses.</p><p><strong>Results: </strong>Our results indicated that high levels of Eotaxin, regulated upon activation normal T cell expressed and presumably secreted(RANTES), Interleukin-2(IL-2), macrophage migration inhibitory factor(MIF), tumor necrosis factor-related apoptosis-inducing ligand(TRAIL) and Stem cell factor(SCF) were associated with increased risks of NAFLD, while high Cutaneous T cell-attracting chemokine(CTACK) and Interleukin-16(IL-16) levels that reduced the risk of NAFLD.The proportion of genetically predicted NAFLD mediated by ferritin was 2.1%(95% CI = 1.39%-5.61%).</p><p><strong>Conclusion: </strong>In conclusion, our study identified a causal relationship between inflammatory cytokines and NAFLD, with a small proportion of the effect mediated by ferritin, but a majority of the effect of inflammatory cytokines on NAFLD remains unclear. Further research is needed on additional risk factors as potential mediators.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1437999"},"PeriodicalIF":3.9,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581845/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global burden of type 2 diabetes mellitus from 1990 to 2021, with projections of prevalence to 2044: a systematic analysis across SDI levels for the global burden of disease study 2021. 1990 年至 2021 年 2 型糖尿病的全球负担,以及到 2044 年的患病率预测:2021 年全球疾病负担研究对不同 SDI 水平的系统分析。
IF 3.9 2区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-11-08 eCollection Date: 2024-01-01 DOI: 10.3389/fendo.2024.1501690
Ke-Jie He, Haitao Wang, Jianguang Xu, Guoyu Gong, Xu Liu, Huiting Guan

Background: We aimed to assess temporal trends in type 2 diabetes mellitus (T2DM)-related deaths and disability-adjusted life years (DALYs) at global and cross-social demographic index (SDI) levels, using data from the Global Burden of Disease (GBD) in 2021.

Methods: We used geospatial mapping to visualize the global distribution of T2DM-related mortality and DALYs in 2021. Joinpoint regression assessed annual and average percent changes in DALYs and deaths from 1990 to 2021 across SDI regions. Age-period-cohort modeling examined the effects of age, period, and cohort on trends. Decomposition analysis evaluated the impact of population growth, aging, and epidemiological changes on DALY trends. A stratified projection forecasted future T2DM burden by age and sex from 2020 to 2044.

Results: T2DM-related mortality and DALYs were highest in low-SDI regions. Globally, T2DM-related deaths and DALYs have increased, with the most rapid rise in low and low-middle SDI regions, driven by population growth and epidemiological shifts. High-SDI countries showed a slower increase in DALYs, influenced more by aging. Age-period-cohort analysis indicated higher DALY rates in later birth cohorts and recent periods, especially in high-SDI regions. Future projections show a significant increase in the 70-74 age group and a gradual rise in other age groups.

Conclusion: The burden of T2DM is projected to continue increasing, especially in low-SDI and low-middle SDI regions, where population growth and epidemiological shifts are the main contributors. This underscores the need for targeted, region-specific healthcare policies, preventive strategies, and age-specific interventions to address the increasing T2DM burden globally.

背景:我们旨在利用2021年全球疾病负担(GBD)的数据,在全球和跨社会人口指数(SDI)层面评估2型糖尿病(T2DM)相关死亡和残疾调整生命年(DALYs)的时间趋势:我们使用地理空间制图来直观显示 2021 年 T2DM 相关死亡率和残疾调整寿命年数的全球分布情况。连接点回归评估了 1990 年至 2021 年各 SDI 地区 DALYs 和死亡人数的年度和平均百分比变化。年龄-时期-队列模型检验了年龄、时期和队列对趋势的影响。分解分析评估了人口增长、老龄化和流行病学变化对 DALY 趋势的影响。一项分层预测按年龄和性别对 2020 年至 2044 年 T2DM 的未来负担进行了预测:结果:与 T2DM 相关的死亡率和残疾调整寿命年数在低 SDI 地区最高。在全球范围内,与 T2DM 相关的死亡率和残疾调整寿命年数都有所上升,其中低 SDI 和中低 SDI 地区的上升速度最快,这主要是受人口增长和流行病学变化的影响。高 SDI 国家的残疾调整寿命年数增长较慢,更多是受老龄化的影响。年龄段-队列分析表明,出生队列较晚和近期的残疾调整寿命年数比率较高,尤其是在高 SDI 地区。未来预测显示,70-74 岁年龄组的残疾调整寿命年数将显著增加,而其他年龄组的残疾调整寿命年数将逐渐增加:结论:预计 T2DM 的负担将继续增加,尤其是在低 SDI 和中低 SDI 地区,人口增长和流行病学变化是主要原因。这突出表明,有必要制定有针对性的、针对特定地区的医疗保健政策、预防策略和针对特定年龄段的干预措施,以应对全球不断增加的 T2DM 负担。
{"title":"Global burden of type 2 diabetes mellitus from 1990 to 2021, with projections of prevalence to 2044: a systematic analysis across SDI levels for the global burden of disease study 2021.","authors":"Ke-Jie He, Haitao Wang, Jianguang Xu, Guoyu Gong, Xu Liu, Huiting Guan","doi":"10.3389/fendo.2024.1501690","DOIUrl":"10.3389/fendo.2024.1501690","url":null,"abstract":"<p><strong>Background: </strong>We aimed to assess temporal trends in type 2 diabetes mellitus (T2DM)-related deaths and disability-adjusted life years (DALYs) at global and cross-social demographic index (SDI) levels, using data from the Global Burden of Disease (GBD) in 2021.</p><p><strong>Methods: </strong>We used geospatial mapping to visualize the global distribution of T2DM-related mortality and DALYs in 2021. Joinpoint regression assessed annual and average percent changes in DALYs and deaths from 1990 to 2021 across SDI regions. Age-period-cohort modeling examined the effects of age, period, and cohort on trends. Decomposition analysis evaluated the impact of population growth, aging, and epidemiological changes on DALY trends. A stratified projection forecasted future T2DM burden by age and sex from 2020 to 2044.</p><p><strong>Results: </strong>T2DM-related mortality and DALYs were highest in low-SDI regions. Globally, T2DM-related deaths and DALYs have increased, with the most rapid rise in low and low-middle SDI regions, driven by population growth and epidemiological shifts. High-SDI countries showed a slower increase in DALYs, influenced more by aging. Age-period-cohort analysis indicated higher DALY rates in later birth cohorts and recent periods, especially in high-SDI regions. Future projections show a significant increase in the 70-74 age group and a gradual rise in other age groups.</p><p><strong>Conclusion: </strong>The burden of T2DM is projected to continue increasing, especially in low-SDI and low-middle SDI regions, where population growth and epidemiological shifts are the main contributors. This underscores the need for targeted, region-specific healthcare policies, preventive strategies, and age-specific interventions to address the increasing T2DM burden globally.</p>","PeriodicalId":12447,"journal":{"name":"Frontiers in Endocrinology","volume":"15 ","pages":"1501690"},"PeriodicalIF":3.9,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142709751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1